Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Crispr Therapeutics AG (CRSP)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Crispr Therapeutics's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create a new watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
124.52 +7.10    +6.05%
17/09 - Closed. Currency in USD ( Disclaimer )
After Hours
124.10
-0.42
-0.34%
19:38:15 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  CH0334081137 
  • Volume: 1,670,872
  • Bid/Ask: 123.85 / 124.04
  • Day's Range: 115.96 - 124.79
Crispr Therapeutics 124.52 +7.10 +6.05%

CRSP Historical Data

 
Get free historical data for CRSP. You'll find the closing price, open, high, low, change and %change of the Crispr Therapeutics AG Stock for the selected range of dates. The data can be viewed in daily, weekly or monthly time intervals. At the bottom of the table you'll find the data summary for the selected range of dates.
Time Frame:
08/19/2021 - 09/19/2021
 
Download Data
Date Price Open High Low Vol. Change %
Sep 17, 2021 124.52 117.62 124.71 116.00 1.67M 6.05%
Sep 16, 2021 117.42 116.90 118.50 114.64 627.75K 0.14%
Sep 15, 2021 117.26 116.21 117.34 114.42 766.27K 0.83%
Sep 14, 2021 116.30 118.31 120.50 115.83 772.13K -1.44%
Sep 13, 2021 118.00 120.91 120.91 116.56 1.25M -2.27%
Sep 10, 2021 120.74 122.43 123.38 120.29 652.24K -0.59%
Sep 09, 2021 121.46 119.55 124.25 119.37 784.20K 1.84%
Sep 08, 2021 119.26 120.08 122.53 117.54 911.72K -1.04%
Sep 07, 2021 120.51 121.59 124.38 120.18 891.29K -1.19%
Sep 03, 2021 121.96 127.83 127.83 121.15 1.00M -4.02%
Sep 02, 2021 127.07 126.69 127.50 124.70 729.44K 0.56%
Sep 01, 2021 126.36 125.14 129.50 124.82 1.07M 1.13%
Aug 31, 2021 124.95 122.34 124.95 122.00 748.88K 3.51%
Aug 30, 2021 120.71 124.71 125.79 120.60 608.52K -2.50%
Aug 27, 2021 123.81 122.67 127.32 120.70 690.44K 1.57%
Aug 26, 2021 121.90 125.15 128.50 121.58 821.43K -3.10%
Aug 25, 2021 125.80 125.34 126.50 123.60 505.89K -0.52%
Aug 24, 2021 126.46 126.58 126.70 123.00 741.87K 1.15%
Aug 23, 2021 125.02 120.39 126.47 119.50 1.25M 6.65%
Aug 20, 2021 117.22 116.58 120.00 115.60 745.56K 0.37%
Aug 19, 2021 116.79 118.16 120.87 116.31 1.09M -2.12%
Highest: 129.50 Lowest: 114.42 Difference: 15.08 Average: 121.60 Change %: 4.36
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

CRSP Comments

Write your thoughts about Crispr Therapeutics AG
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Fabrizio Lombardo
Fabrizio Lombardo Sep 16, 2021 10:07AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
97 usd  is a good entry point...
Reply
1 1
Report
Nuno Da Silva
Nuno Da Silva Aug 30, 2021 1:47PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
a classic Cathy wood collapse
Reply
0 6
Report
Jonathan badham
Jonathan badham Aug 17, 2021 7:15PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
how do you actually buy shares i have a buy sell window open but its an ad i wanna actually buy a stock not be sent to yet another bs broker app
Reply
0 0
Report
steve loeschke
steve loeschke Aug 17, 2021 7:15PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Check if you Bank can help you out
Reply
0 0
Report
John Brand
John Brand Aug 17, 2021 7:15PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Open and fund a brokerage account. There are many options.
Reply
0 0
Report
Barak David
Barak David Aug 02, 2021 3:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
wow
Reply
0 0
Report
Ray Weber
Ray Weber Jul 29, 2021 5:02PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Beat on earnings!! Largly
Reply
3 0
Report
kyle dvorsky
kyle dvorsky Jul 26, 2021 4:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Problem with this one is you're gonna need to wait a literal decade for it to be viable, regardless of studies/tests.
Reply
2 0
Report
palmer gossett
palmer gossett Jul 26, 2021 4:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
true
Reply
0 0
Report
Ray Weber
Ray Weber Jul 26, 2021 4:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think in a normal world… Definitely. My opinion, it right around the corner.
Reply
1 0
Report
Nuno Da Silva
Nuno Da Silva Jul 26, 2021 1:01PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
total bubble of cathie wollod pump
Reply
0 3
Report
도리 Dori
도리 Dori Jul 19, 2021 3:00AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
CRSP and AIRI are Good stockAIRI will go up to X3
Reply
1 0
Report
palmer gossett
palmer gossett Jul 13, 2021 7:54PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
keep on dropping...
Reply
2 0
Report
Nuno Da Silva
Nuno Da Silva Jul 08, 2021 9:15AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
good entry point is around 80
Reply
1 2
Report
palmer gossett
palmer gossett Jul 06, 2021 8:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
keep dropping, want to get back in
Reply
1 0
Report
Ray Weber
Ray Weber Jul 05, 2021 6:34AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
206 by Oct
Reply
4 1
Report
Adam Anderson
Adam Anderson Jul 05, 2021 6:34AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
That would be acceptable.
Reply
0 0
Report
Serdar Altinel
Serdar Altinel Jul 02, 2021 4:00AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Last weekend, Intellia Therapeutics and Regeneron announced first-ever clinical data that support the safety and efficacy of in vivo CRISPR genome editing in humans. We summarise the findings here.
Reply
3 0
Report
Pro Investor
Pro Investor Jun 30, 2021 6:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ride it to new highs
Reply
7 0
Report
Mayadachi Ikechi
Mayadachi Jun 28, 2021 10:57AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Alert: Crispr Therapeutics will acquire AGTC before end of FY2021 as a strategy to get into the ophthalmology space. Load up now & Stay tuned
Reply
8 0
Report
palmer gossett
palmer gossett Jun 28, 2021 10:57AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ok, thanks
Reply
0 0
Report
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 28, 2021 10:57AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Thank you, but may we know your source, please?
Reply
0 0
Report
Mary Miller
Mary Miller Jun 28, 2021 10:57AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What proof or source do you have that these facts have changed? See quote:  Gene therapy developer AGTC lost nearly half its market cap Thursday morning after Biogen exited a collaboration agreement on the heels of a big clinical failure. Interim six-month data on one of AGTC's investigational therapies showed it was generally safe but ineffective at treating a rare eye disorder known as X-linked retinoschisis (XLRS). The company plans to complete patient monitoring activities on the XLRS program but will not develop it further.
Reply
1 0
Report
Neek Kajula
Neek Kajula Jun 28, 2021 7:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Held the dip, looks great
Reply
3 0
Report
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 28, 2021 6:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i think that someone knew the news about intellia on friday already and then bought Crispr quickly.
Reply
1 0
Report
Barak David
Barak David Jun 28, 2021 6:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i thought the same.. lucky enough it was good news
Reply
2 0
Report
Adam Anderson
Adam Anderson Jun 28, 2021 4:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ouch...shorts are about to get crushed
Reply
3 0
Report
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 26, 2021 2:23PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It will most likely go higher on monday due to good results from Intellia.
Reply
5 0
Report
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 24, 2021 12:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Any reason why it's up over 5% today?
Reply
2 0
Report
Terminal Velocity
Terminal Velocity Jun 24, 2021 11:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
lander.gates.fauci
Reply
0 0
Report
palmer gossett
palmer gossett Jun 15, 2021 9:01PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
buying more around $100
Reply
1 1
Report
Adam Anderson
Adam Anderson Jun 15, 2021 9:01PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Thank you for your insight...please take your seat now.
Reply
4 0
Report
Adam Anderson
Adam Anderson Jun 11, 2021 8:30AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
short squeeze coming
Reply
7 1
Report
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 11, 2021 8:03AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://www.businesswire.com/news/home/20210611005069/en/Vertex-and-CRISPR-Therapeutics-Present-New-Data-in-22-Patients-With-Greater-Than-3-Months-Follow-Up-Post-Treatment-With-Investigational-CRISPRCas9-Gene-Editing-Therapy-CTX001%E2%84%A2-at-European-Hematology-Association-Annual-Meeting
Reply
3 0
Report
Rajesh Kumar
Rajesh Kumar Jun 08, 2021 10:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Good n3ws is coming . About to breakout to $130
Reply
4 1
Report
palmer gossett
palmer gossett Jun 08, 2021 10:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what news
Reply
0 0
Report
Rajesh Kumar
Rajesh Kumar Jun 08, 2021 10:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
There are two health care conferences on Jun 8 and Jun 11. I am expecting good news about crsp from both conferences.
Reply
3 0
Report
Andrew Kittle
Andrew Kittle Jun 08, 2021 10:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ongoing CLIMB SCD-121 Study of Autologous Crispr-Cas9-Modified CD34+ Hematopoietic Stem and Progenitor Cells,” will be made available on the virtual platform as an e-poster Friday, June 11 at
Reply
0 0
Report
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 08, 2021 10:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Well done, Rajesh Kumar!
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email